Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.03 (-5.26%)
Close on Nov 18, 2026Market cap $3.25MP/E –Yield –
Imunon revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Imunon's revenue for the twelve months ending Dec 31, 2022 was $500.00K, up 0.0% year over year. For fiscal 2022 it was $500.00K, up 0.0% from the year before. The highest annual figure on record is $500.00K in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $500.00K | 0.0% |
| FY2021 | Dec 31, 2021 | $500.00K | 0.0% |
| FY2020 | Dec 31, 2020 | $500.00K | 0.0% |
| FY2019 | Dec 31, 2019 | $500.00K | 0.0% |
| FY2018 | Dec 31, 2018 | $500.00K | 0.0% |
| FY2017 | Dec 31, 2017 | $500.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $125.00K | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $125.00K | 0.0% |
| Q2 FY2022 | Jun 30, 2022 | $125.00K | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $125.00K | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | $125.00K | 0.0% |
| Q3 FY2021 | Sep 30, 2021 | $125.00K | 0.0% |
| Q2 FY2021 | Jun 30, 2021 | $125.00K | 0.0% |
| Q1 FY2021 | Mar 31, 2021 | $125.00K | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | $125.00K | 0.0% |
| Q3 FY2020 | Sep 30, 2020 | $125.00K | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $125.00K | 0.0% |
| Q1 FY2020 | Mar 31, 2020 | $125.00K | 0.0% |
| Q4 FY2019 | Dec 31, 2019 | $125.00K | 0.0% |
| Q3 FY2019 | Sep 30, 2019 | $125.00K | 0.0% |
| Q2 FY2019 | Jun 30, 2019 | $125.00K | 0.0% |
| Q1 FY2019 | Mar 31, 2019 | $125.00K | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | $125.00K | 0.0% |
| Q3 FY2018 | Sep 30, 2018 | $125.00K | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | $125.00K | 0.0% |
| Q1 FY2018 | Mar 31, 2018 | $125.00K | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | $125.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $125.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $125.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $125.00K | – |
See a number that looks wrong?